BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Biotechnology Magazine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:European Biotechnology Magazine
X-ORIGINAL-URL:https://european-biotechnology.com
X-WR-CALDESC:Events for European Biotechnology Magazine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260504
DTEND;VALUE=DATE:20260506
DTSTAMP:20260503T221038
CREATED:20260402T171655Z
LAST-MODIFIED:20260402T172420Z
UID:20032-1777852800-1778025599@european-biotechnology.com
SUMMARY:Swiss Biotech Day 2026
DESCRIPTION:Since 2021\, the Swiss Biotech Day has grown by an average of 35% every year and has become a premier global biotechnology conference for life sciences professionals\, fostering international collaboration and impactful partnerships. In 2025 it attracted more than 3\,000 participants from 49 countries\, including 25 international delegations. \nJoin the Swiss Biotech Day to network\, exchange ideas and explore advances in R&D\, manufacturing\, data management\, AI and innovative financing. In addition\, the embedded Global Village provides international delegations a platform to strengthen their ties with the Swiss biotech hub to promote cross-border investments\, public-private partnerships\, R&D collaborations and the exchange of best practices. \nThe conference highlights include a welcome reception on May 3\, over 130 exhibitors\, and the Global Village with around 30 international delegations from across the world. The program also features presentations by innovative biotech start-ups and mid-sized companies\, as well as more than 50 thematic company pitching sessions and panel or round table discussions. It is complemented by the launch of the Swiss Biotech Report 2026\, pre-scheduled one-to-one partnering meetings\, the Swiss Biotech Success Stories Awards\, and the General Assembly of the Swiss Biotech Association. \nRegister here.
URL:https://european-biotechnology.com/highlight/swiss-biotech-day-2026/
LOCATION:Congress Center Basel\, Messeplatz 21\, Basel\, 4050\, Switzerland
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/04/SBA-Banner-Ad-SBD-2026-960x540px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260506
DTEND;VALUE=DATE:20260508
DTSTAMP:20260503T221038
CREATED:20260210T130340Z
LAST-MODIFIED:20260210T130340Z
UID:19225-1778025600-1778198399@european-biotechnology.com
SUMMARY:Chemspec Europe 2026: Where chemistry connects
DESCRIPTION:Chemspec Europe 2026 brings together producers\, procurement professionals and technical experts from across the fine and speciality chemicals landscape. Spanning industries including pharmaceuticals\, agrochemicals\, speciality materials\, coatings\, personal care\, electronics and energy\, the event offers a focused snapshot of how the sector is responding to regulatory pressure\, sustainability demands and ongoing supply chain complexity. \nMore than 400 global suppliers are expected to be represented on the exhibition floor\, covering custom synthesis\, contract manufacturing\, formulation\, scale-up and specialist services. Companies such as Albemarle\, Brenntag\, CABB Group\, Johnson Matthey\, Saltigo and Yashashvi Rasayan will be among those showcasing their capabilities\, giving visitors direct insight into current approaches and expertise across the value chain. \nAlongside the exhibition\, Chemspec Europe 2026 features two complementary conference streams designed to reflect both the technical and strategic realities of today’s market. \nThe Moleküle Hub focuses on how chemistry is developed\, manufactured and scaled. Sessions explore the growing role of digitalisation\, automation and artificial intelligence in R&D and production\, alongside advances in continuous processing and modular manufacturing. Practical case studies will show how companies are moving innovations from lab to commercial scale more efficiently\, safely and sustainably. \nRunning in parallel\, the Strategy Stage takes a broader view of the forces shaping fine and speciality chemicals. Discussions address market resilience\, collaboration\, talent and growth strategies\, offering perspective on how companies are adapting to change and identifying new opportunities in a complex global environment. \nTogether\, the exhibition and conference programme provide a clear picture of where change is happening fastest in fine and speciality chemicals and how the sector is evolving. Chemspec Europe 2026 creates space for informed discussion\, practical insight and meaningful connection across the community. \nFor more information and registration visit chemspeceurope.com
URL:https://european-biotechnology.com/highlight/chemspec-europe-2026-where-chemistry-connects/
LOCATION:Koelnmesse\, Cologne\, Germany
CATEGORIES:highlight
ATTACH;FMTTYPE=image/png:https://european-biotechnology.com/wp-content/uploads/2026/02/4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260519
DTEND;VALUE=DATE:20260522
DTSTAMP:20260503T221038
CREATED:20260323T164239Z
LAST-MODIFIED:20260326T062550Z
UID:19933-1779148800-1779407999@european-biotechnology.com
SUMMARY:A special look at SLAS Europe Conference
DESCRIPTION:The Society for Laboratory Automation and Screening (SLAS) will unite the European life sciences and laboratory technology community in Vienna\, Austria\, 19–21 May 2026\, for the SLAS Europe 2026 Conference & Exhibition. \nThe 2026 conference features three scientific tracks: Advances in Drug Discovery\, Advances in Laboratory Automation\, and Screening Applications & Diagnostics. Each track is comprised of four sessions led by subject-matter experts drawn from leading academic and industry institutions across Europe. All session times and locations are available at slas.org/europe2026-schedule. \nAbstract submissions are still being accepted for poster presentations until Monday\, 27 April. SLAS invites research scientists\, engineers\, academics\, students and business leaders to submit an abstract. The SLAS Europe conference offers highly interactive platforms to showcase work\, engage in detailed discussions with delegates\, and network with diverse professionals across the European life sciences. \nThe conference will open with a keynote address from Willem Mulder\, PhD\, Professor of Precision Medicine at Radboud University Medical Center and Eindhoven University of Technology. As a biomedical engineer\, inventor\, and entrepreneur\, Mulder reflects the diverse SLAS community and will undoubtedly challenge and inspire all in attendance to continue shaping the future of life sciences. \nThe highly anticipated Technology Provider Showcase will take place on Tuesday\, 19 May\, at the Vienna BioCenter – co-hosted by Vienna BioCenter Core Facilities (VBCF) GmbH. The Vienna BioCenter campus is home to seven research institutions\, 2\,000 scientists\, and 42 biotech startups\, making it one of Europe’s most dynamic life sciences ecosystems. \nTwo half-day sessions are available (morning and afternoon)\, each with limited space\, creating a unique and intimate experience. Both sessions open with a presentation from VBCF\, followed by talks from a curated selection of innovative companies and startups: \nAkribes Biomedical – utilising protein barcodes to personalise wound treatment.\nMyllia – using CRISPR perturbations and single-cell sequencing for drug target screening.\nChan:Pharma – will showcase their automated patch-clamp system.\nBioNTech Austria – will present their antibiotic drug screening platform. \nStefan Kubicek\, PhD\, from the Centre for Molecular Medicine (CeMM)\, will also present his automated small-molecule screening platform. Early registration is strongly encouraged as spaces are strictly limited. Learn more by visiting slas.org/europe2026-showcase. \nThe conference exhibition will feature over 100 exhibitors showcasing the latest technologies\, services and products driving innovation in lab automation and life sciences. Delegates will have dedicated time to explore new product demonstrations\, exhibitor tutorials\, and Solutions Spotlight and SLAS Ignite Theater presentations\, as well as visit the 12 emerging start-up companies in the Innovation AveNEW area. Daily social events and meals will offer numerous opportunities for networking and collaboration in a relaxed atmosphere. \nEarly registration for SLAS Europe 2026 is open\, with several options and rates available\, including full-conference\, exhibition-only\, student rate\, and more. Visit slas.org/europe2026 for complete conference details and to register for the Vienna conference. \nAhead of the conference\, SLAS will host a free\, regional networking event for the life sciences community to connect. Catch the SLAS Meet-Up at ETH Zürich in Basel\, Switzerland\, (30 April) just ahead of Swiss Biotech Days. This gathering will offer excellent opportunities to build connections across the European life sciences community. Visit slas.org/events-calendar to register for an upcoming Meet-Up.
URL:https://european-biotechnology.com/highlight/a-special-look-at-slas-europe-conference/
LOCATION:Vienna Congress & Convention Center\, Vienna\, Austria
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/03/SLAS-EU26-Banner_960x540-Kopie.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260609
DTEND;VALUE=DATE:20260612
DTSTAMP:20260503T221038
CREATED:20260121T101449Z
LAST-MODIFIED:20260318T150146Z
UID:18986-1780963200-1781222399@european-biotechnology.com
SUMMARY:bio:cap 2026
DESCRIPTION:Bio:cap 2026 brings together the global Life Science and AI ecosystem at the City Cube on the Berlin exhibition grounds. The event blends the focus of an investor conference with the energy of a festival: curated matchmaking\, inspiring keynotes\, deep-dive sessions\, and interactive panels highlight innovations in biotech\, diagnostics\, and AI-driven health solutions. Networking is at the heart of bio:cap\, with dedicated zones for founder-investor 1:1s\, a Capital Zone for VCs and family offices\, and informal lounge areas for spontaneous conversations. Attendees also experience Berlin’s unique vibe: move between idea-sparking installations\, discover partner innovations at their booths\, or grab snacks and drinks at a Berlin-style Späti. \nBerlin’s dense network of leading universities\, research institutions\, and biotech startups provides the perfect environment for innovation and collaboration\, making it an ideal host city for bio:cap. The event is shaped in close partnership with the ­Charité\, BIH and HPI\, supported by leading figures such as Prof. Heyo Kroemer (CEO\, Charité)\, Prof. Eicke Latz (immunologist and life science investor)\, and Prof. Ariel Stern (HPI)\, a leading voice at the intersection of digital health\, economics\, and policy. \nOn the second evening\, the official bio:cap Investival Party turns a hand-picked Berlin venue into a hub for vibrant discussions and new collaborations. \nBy combining strategic networking\, cutting-edge science\, and Berlin’s dynamic lifestyle\, bio:cap showcases the future of Life Sciences and AI\, making it a must-attend event for startups\, investors\, researchers\, and policymakers worldwide.
URL:https://european-biotechnology.com/highlight/biocap-2026/
LOCATION:City Cube Berlin\, Germany
CATEGORIES:highlight
ATTACH;FMTTYPE=image/jpeg:https://european-biotechnology.com/wp-content/uploads/2026/01/biocap_26_Eingang_City-Cube-scaled-e1768990436347.jpg
END:VEVENT
END:VCALENDAR